Skip to main content
  • 216 Accesses

Zusammenfassung

Wachstumshormon (Syn. Somatotropin, somatotropes Hormon = STH, growth hormone = GH) ist ein einkettiges Peptidhormon aufgebaut aus 191 Aminosäuren (AS) ohne Zuckerreste, welches über 2 Disulfidbrücken in seine Tertiärstruktur gefaltet ist. Diese besteht aus 4 α-Helices, die antiparallel angeordnet sind. Wachstumshormon ist das Produkt des GH-1(GH-N)-Gens, welches zusammen mit Genen für humanes Chorionsomatomammotropin (hCS) und dem nur in der Plazenta exprimierten GH-2(GH-V)-Gen auf dem langen Arm des Chromosoms 17 lokalisiert ist. Neben GH mit einem Molekulargwicht von 22 kD (ca. 90%) entsteht durch alternatives Splicing eine Pro tein variante (20 kD, ca. 10%), dem die AS 32-46 der 22-kD-Form fehlen. Darüber hinaus existieren im Blut in geringeren Konzentrationen, jedoch individuell variierend, weitere GH-Varianten und Oligomere (z. B. „big“ GH) mit unterschiedlicher biologischer Aktivität. Die Expression des GH-1-Gens ist fast ausschließlich auf die somatotropen Zellen der Adenohypophyse beschränkt, welche ca. 90% ihrer Zellmasse ausmachen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur zu Abschn. 7.7-7.2

  • Baumann G. (1991) Growth hormone heterogeneity: Genes, isohormones, variants, and binding protein. Endocrine Rev 12: 424–449

    Article  CAS  Google Scholar 

  • de Boer H., van der Veen E. (1997) Guidelines for optimizing growth hormone replacement therapy in adults. Horm Res 48 (Suppl 5):21–30

    Article  PubMed  Google Scholar 

  • Frisch H. (1997) Clinical review of pediatric indications for treatment with growth hormone. In: M.B. Ranke (ed) J.A. Barth, Growth hormone over the human life span. Edition J & J, Heidelberg, pp 8–24

    Google Scholar 

  • Moeller N. (1993) The role of growth hormone in the regulation of human fuel metabolism. In: Flyvbjerg A., Orskov H., Alberti K.G.M.M. (eds) Growth hormone and insulin-like growth factor I. Wiley, New York, pp 77–108

    Google Scholar 

  • Ranke M.B. (1994) Growth hormone insufficiency: Clinical features, diagnosis, and therapy. In: L. DeGroot (ed) Endocrinology 3rd edn, Saunders, Philadelphia, pp 330–340

    Google Scholar 

  • Ranke M.B., Elmlinger M. (1997) Functional role of insulin-like growth factor bin ding proteins. Horm Res 48 (Suppl 4):9–15

    Article  PubMed  CAS  Google Scholar 

  • Ranke M.B. (ed) (1996) Diagnostics of endocrine function in children and adolescents, Edition J & J, Heidelberg

    Google Scholar 

  • Rosenfeld R.G., Albertsson-Wikland K. et al. (1995) Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80: 1532–1540

    Article  PubMed  CAS  Google Scholar 

  • Smith R.G., van der Ploeg L.H.T., Howard A.D. et al. (1997) Peptidomimetic regulation of growth hormone secretion. Endocrine Rev 18: 621–645

    Article  CAS  Google Scholar 

  • Thorner M.O., Bengtsson B.A., Ho K.Y. et al. (1995) Letter to the editor. The diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab 80: 3097–3098

    Article  PubMed  CAS  Google Scholar 

  • Wüster C., von zur Mühlen A., Ranke M.B. (1994) Das Syndrom des W.achstumshormonmangels beim Erwachsenen, Dtsch Arzteblatt 91: B–1795–B1796

    Google Scholar 

Literatur zu Abschn. 7.7-7.2

  • Brämswig J., von Lengerke H.J., Schmidt H., Schellong G. (1988) The results of shortterm high-dose testosterone treatment on bone age and adult heigth in boys of excessively tall stature. Europ J Pediat 148: 104–106

    Article  PubMed  Google Scholar 

  • Engström W.S., Lindharn S., Schofield P. (1988) WiedemannBeckwith syndrome. Europ J Pediat 147: 450–457

    Article  PubMed  Google Scholar 

  • Gordon P., Corni R.J., Maton P.N., Go V.L.W. (1989) Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 110: 35–39

    Article  Google Scholar 

  • Jones K.L. (1994) The etiology and diagnosis of overgrowth syndromes. Growth Genetics Hormones 10: 6–10

    Google Scholar 

  • Kaplan S.L., Grumbach M.M. (1990) Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 71:785–791

    Article  PubMed  CAS  Google Scholar 

  • Moses A.E., Molitch M.E., Sawin C.T. (1981) Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effeet on serum levels of somatomedin C. J Clin Endocrinol Metab 53: 752–757

    Article  PubMed  CAS  Google Scholar 

  • Mudd S.H., Skovby F., Levy H.L. (1985) The natural history of homocystinuria due to eystathionine-B-synthase deficiency. Am J Hum Genet 37: 1–7

    PubMed  CAS  Google Scholar 

  • Norman E.K., Tygstad O., Larsen S., Dahl-Jorgensen K. (1991) Height reduction in 539 tall girls treated with three different dosages of ethinyloestradial. Arch Dis Childh 66: 1275–1278

    Article  Google Scholar 

  • Plymate S.R.: Male hypogonadism. In: Becker K.L. (1995) Principles and praetice of endocrinology and metabolism. Lippincott, pp 1057–1082

    Google Scholar 

  • Quabbe H.J., Müller O.A., Oelkers W., Willig R.P. (1993) Wachstumshormonexzess. In: Ziegler R., Pickardt C.R., Willig R.P. (eds) Rationelle Diagnostik in derEndokrinologie. Thieme, S9–10

    Google Scholar 

  • Reinken L., von Oost G. (1992) Longitudianle Körperentwicklung gesunder Kinder von 0 bis 18 Jahren. Körperlänge,-höhe, Körpergewicht und Wachstumsgeschwindigkeit. Klin Pädiat 204: 129–133

    Article  CAS  Google Scholar 

  • Willig R.P., Bettendorf M., Hinkel G.K., Schwarz H.P., Schulze W. (1992) Androgen treatment of tall stature during puberty may reduce sperm quality in adult life. Hormone Res 37 (Suppl 4):3

    Article  Google Scholar 

Literatur zu Abschn. 7.4

  • Bengtsson B., Eden S., Ernest I., Oden A., Sjögren B. (1988) Epidemiology and long-term survival in aeromegaly. Acta Med Scand 233: 327–335

    Google Scholar 

  • Clemmons D.R., van Wyk J.J., Redgeway E.C., Klima B., Kjellber R.N., Underwood L.E. (1979) Evaluation of acromegaly by radioimmunoassay of somatostatin C. New Engl J Med 301: 1138–1142

    Article  PubMed  CAS  Google Scholar 

  • Faglio G., Arosio M., Bazzoni N. (1992) Ectopic acromegaly. Endocrinol Metab Clin North Am 21: 575–577

    Google Scholar 

  • Fahlbusch R., Buchfelder M., Schrell U. (1985) Neurochirurgische Therapie neuroendokrinologischer Störungen. Internist 26: 293–301

    PubMed  CAS  Google Scholar 

  • Lamberts S.W., Reubi J.C., Krenning E.P. (1992) Somatostatin analogs in the treatment of acromegaly. Endocrinol Metab Clin North Am 21: 737–740

    PubMed  CAS  Google Scholar 

  • Losa M., Schopohl J., von Werder K. (1993) Ectopic secretion of growth hormone in man. J Endocr Invest 16: 69–81

    PubMed  CAS  Google Scholar 

  • Nyquist P., Laws E.R., Elliott R.N. (1994) Novel features oftumors that secrete both growth hormone and prolactin in acromegaly. Neurosurgery 35: 179–184

    Article  PubMed  CAS  Google Scholar 

  • O’Duffy J.D., Randall R.V., MacCarry C.S. (1973) Median neuropathy (carpal tunnel syndrome in acromegaly. Ann Intern Med 78: 379–384

    Article  CAS  Google Scholar 

  • O’Sullivan A.J.. Kelly J.J., Hoffman D.M. (1994) Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 78: 381–384

    Article  PubMed  Google Scholar 

  • Plöckinger U., Dienemann D., Quabbe H. (1990) Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. J Clin Endocr 71: 1658–1662

    Article  PubMed  Google Scholar 

  • Quabbe H.J., Müller O.A., Oelkers W., Willig R.P. (1993) Wachstumshormonexzess. In: Ziegler R., Pickardt C.R., Willig R.P. (eds) Rationelle Diagnostik in derEndokrinologie. Thieme, S 9–10

    Google Scholar 

  • Ross D.A., Wilson C.B. (1988) Results of transsphenoidal microsurgery for growth hormone secreting pituitary adenoma in aseries of 214 patients. J Neurosurg 68: 854–867

    Article  PubMed  CAS  Google Scholar 

  • Savage D.D., Henry W.L., Easthman R.C. (1979) Echocardiographic assessment of cardiac anatomy and function in acromegalic patients. Am J Med 67: 823–827

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Binder, G., Haak, T., Ranke, M.B., Usadel, K.H. (2001). Wachstum. In: Nawroth, P.P., Ziegler, R. (eds) Klinische Endokrinologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56784-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56784-1_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62970-9

  • Online ISBN: 978-3-642-56784-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics